Given the central role of dysregulated Wnt signaling in oncogenesis [32,33,34,37,38], the ability of AXIN1-295aa to disrupt β-catenin turnover and sustain pathway activation suggests that it may significantly contribute to tumorigenesis and disease progression in gastric cancer. Here, AXIN1 is linked to gastric cancer.